Legend

Scientific Session

Systemic Lupus Erythematosus (SLE)

Session: 2025 ACR Guidelines for the Treatment of Extrarenal Systemic Lupus Erythematosus (SLE)

Applying the Guideline to Treat Cutaneous Lupus

Sunday, October 26, 2025

9:30 AM – 10:00 AM Central Time

Speaker(s)

Victoria Werth, MD

University of Pennsylvania
Wynnewood, PA, United States

Disclosure(s): AbbVie: Consultant (Terminated, March 17, 2022); AbbVie/Abbott: Consultant (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Anaptysbio: Consultant (Ongoing); argenx: Consultant (Ongoing), Grant/Research Support (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Consultant (Ongoing); Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol Myers Squibb: Consultant (Ongoing); Bristol Myers Squibb (BMS): Consultant (Ongoing); Celgene: Consultant (Terminated, October 21, 2021), Grant/Research Support (Terminated, October 21, 2021); Corbus: Grant/Research Support (Terminated, January 11, 2021); CSL Behring: Consultant (Ongoing), Grant/Research Support (Ongoing), Grant/Research Support (Ongoing); Eli Lilly: Consultant (Ongoing); EMD Serono: Consultant (Ongoing); Galderma: Consultant (Ongoing); Genentech: Consultant (Ongoing), Grant/Research Support (Ongoing), Grant/Research Support (Ongoing); Gilead: Consultant (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKline: Consultant (Ongoing); GlaxoSmithKline (GSK): Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing), Grant/Research Support (Ongoing); Idera: Consultant (Ongoing); Incyte: Consultant (Ongoing); Janssen: Consultant (Ongoing); Kyowa Kirin: Consultant (Ongoing); Lilly: Consultant (Ongoing); MedImmune: Consultant (Ongoing); Medscape: Consultant (Ongoing); Merck: Consultant (Ongoing); Merck/MSD: Consultant (Ongoing); Nektar: Consultant (Ongoing); Novartis: Consultant (Ongoing); Octapharma: Consultant (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Principia: Consultant (Ongoing); Regeneron: Consultant (Ongoing), Grant/Research Support (Ongoing), Grant/Research Support (Ongoing); Resolve: Consultant (Ongoing); Rome Pharmaceuticals: Consultant (Ongoing); Rome Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Sanofi: Consultant (Ongoing); Syntimmune: Grant/Research Support (Terminated, December 31, 2021); Ventus: Grant/Research Support (Ongoing); Viela: Consultant (Terminated, May 6, 2022), Consultant (Terminated, May 6, 2022), Grant/Research Support (Terminated, May 6, 2022); Xencor: Consultant (Ongoing)